Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIScovery podcast 50th episode CORDIScovery podcast 50th episode
Contenido archivado el 2024-06-18

European Medicines Research Training Network

Objetivo

EMTRAIN is an essential element for the success of the IMI Education & Training (E&T) Call Topics in Europe (current and future). It will establish a pan-European platform of excellence for education and training covering the whole life-cycle of medicines from basic research through clinical development to pharmaco-vigilance. It will underpin the successful delivery of the current and future IMI-funded E&T projects, and by 2013 will have defined the IMI E&T vision.
In collaboration with the different IMI E&T projects EMTRAIN will ensure training
programmes are tailored in a coordinated way for current and future professionals involved in biomedical R&D. Flexibility and mobility of scientists is required to take advantage of the variety of opportunities at the pan-European level, and to understand European needs in biomedical and pharmaceutical medicines sciences. This capacity building project will build up the infrastructure for the other E&T projects and in future calls initiated by IMI, and will facilitate mobility between academia, industry, regulators, and other relevant stakeholders/potential employers.
Based on extensive mapping of existing resources in Europe and on a gap and overlap
analysis, the consortium will develop and implement a strategy for pan-European expansion,for harmonisation and accreditation of continuing professional development (CPD) programmes in context of life-long learning under the umbrella of the IMI cross-project LifeTrain initiative (WP4/7). The consortium will provide a comprehensive registry of Master level and PhD programmes, as well as of CPD programmes. It will provide an overview of existing innovative learning concepts, tools and methodologies in conjunction with the other IMI E&T projects that will support the content for the IMI education programmes. National implementation will be facilitated through close contacts with national university authorities, ministries of higher education, and through the availability of national liaison contact persons.
After implementation in a core group of institutions, extension is planned both within the countries represented in EMTRAIN and in additional countries, helped by dissemination and communication activities. The harmonisation and the modular nature of these programmes will allow trans-disciplinary curricula as well as trans-border and trans-sectoral mobility, and PhD programmes will be designed to foster industry/academia mobility and collaboration.
The public Consortium is made up of the six pan-European biomedical science (BMS)
research infrastructures from the ESFRI roadmap, and the Medizinische Universitaet Wien
as managing entity. The six ESFRI-BMS research infrastructures cover a broad spectrum of
competences from molecules to humans: structural biology (Instruct), bioinformatics
(ELIXIR), animal models (INFRAFRONTIER), biobanks (BBMRI), translational research
(EATRIS) and clinical research (ECRIN). These distributed infrastructures are based on
resources and facilities located in a majority of EU countries, and have their own education and training programmes. EMTRAIN can therefore take advantage of their broad spectrum of competences, of their pan-European dimension, of their close contacts with national authorities (national ministries of higher education and research are partners in these initiatives), and of already existing national liaisons. Members of the six ESFRI-BMS infrastructures will be responsible for leading the work packages WPs 2-9 in collaboration with members of the EFPIA.
The EFPIA consortium has considerable experience in education and training; management;
provides a pan-European geographical outreach, and draws on an extensive external
network of contacts. Therefore, the EFPIA consortium will not only be able to provide specific input relating to the needs of the pharmaceutical industry but, by contributing to the work packages in partnership with the public consortium, will also

Programa(s)

Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.

Tema(s)

Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.

Convocatoria de propuestas

Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.

IMI-JU-01-2008
Consulte otros proyectos de esta convocatoria

Régimen de financiación

Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.

JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)

Coordinador

ASTRAZENECA AB
Aportación de la UE
Sin datos
Dirección
Vastra Maelarhamnen
151 85 Sodertaelje
Suecia

Ver en el mapa
Región
Östra Sverige Stockholm Stockholms län
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total

Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.
Sin datos

Participantes (29)

Compartir esta página Compartir esta página en las redes sociales

Descargar Descargar el contenido de la página

Última actualización: 25 Mayo 2022

Mi folleto

Permalink: https://cordis.europa.eu/project/id/115015/es

European Union, 2025

Mi folleto 0 0